Methods for searching stable docking models of biopolymer-ligand

Boots – shoes – and leggings

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

364578, G06T 1740

Patent

active

056422920

DESCRIPTION:

BRIEF SUMMARY
TECHNICAL FIELD

The present invention relates to methods for searching stable docking models of biopolymer-ligand molecule complex that can be utilized in designing the structures of drugs, pesticides, and other biologically active compounds.


BACKGROUND ART

Strong binding of drugs and biologically active substances to their target biopolymers is required for the appearances of their bioactivities. The biopolymers include pharmacological receptors which take part in signal transmission between cells, as well as enzymes, cytokines and other proteins, complexes comprising these proteins as main components, and nucleic acids. Since 1960, the steric structures of a large number of biopolymers have been revealed at the atomic level by X-ray crystallographic analyses and the structural data thereof have been stored in the Protein Data Bank and published.
Small molecules which can be bound to these biopolymers are called ligand molecules. The ligand molecules include candidate molecules for drugs such as drug molecules to be synthesized in future, as well as drugs, substrates and inhibitors of enzymes, coenzymes and the like.
For the stable binding between the biopolymers and ligand molecules it is required that the shapes of cavities which exist in the steric structures of biopolymers and into which ligand molecules are bound (hereinafter referred to as "ligand-binding sites") should be complementary to the shapes of the ligand molecule surfaces as in the case of locks and keys and that there should be interactions between the both molecules which result in specific affinity therebetween. It is known from the crystallographic analyses of biopolymer-ligand molecule complexes that among these intermolecular interactions, hydrogen-bond, electrostatic and hydrophobic interactions and the like are particularly important. In drug design and structure-activity relationship study, it is very important to know whether a compound molecule can form a stable complex with its target biopolymer and, if so, what kind of binding mode the complex has (i.e., which functional group in the ligand-binding site of the biopolymer interact which functional groups in the ligand molecule in what kind of mode) and how stable the complex is. In conformationally flexible ligand molecules, it is also important for drug design to determine the conformation of the ligand molecules bound to target biopolymers (active conformation) and such a determination must be made at the same time as searching stable binding modes.
It is known that when the complexes have the most stable structures in terms of free energy, the ligand molecule structures are often different from the crystal structures of unbound ligand molecules, the structures in solutions, and the energically most stable (or any local minimum) structures obtained by various kinds of energy calculations.
It is impossible to determine the modes of binding of all ligand molecules of interest to their target biopolymer by experimental methods such as X-ray crystallographic analysis. First, this is because a great effort and time are necessary for analyzing the mode of binding of each ligand molecule to the biopolymer by experimental methods. In addition, if the ligand molecules are substrates for enzymes, any stable structures of the complex can not be detected in the experiments due to the progress of enzymatic reactions. Furthermore, the samples of the ligand compounds are often unavailable if they exist. In some cases, it may be required to predict the binding mode and the stability of the complex between an imaginary ligand molecule and its biopolymer, in order to decide whether it is valuable to synthesize the ligand molecule. Such a prediction is very useful in making new drugs and biologically active substances by molecular design.
The simulation study of the mode of stable binding of ligand molecules to their target biopolymer whose structure is known is called "docking study". In the past, the docking study was performed using molecular models, but the use of molecular models had p

REFERENCES:
patent: 5386507 (1995-01-01), Teig et al.
Jiang et al "`Soft Docking`: Matching of Molecular Surface Cubes" J. Mol. Biol. (1991) 219 pp. 79-102.
Desjarlais et al., "Docking Flexible Ligands to Macromolecular Receptors by Molecular Shape" J. Med. Chem (1986) 29 pp. 2149-2153.
Yue, "Distance-Constrained Molecular Docking by Simulated Annealing" Protein Engineering vol. 4, n. 2 pp. 177-184 (1990).
Journal of Chemometrics, vol. 1, No. 3, Jun. 1987, Peter Willett, "A Review of Chemical Structure Retrieval Systems", pp. 139-155.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods for searching stable docking models of biopolymer-ligand does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for searching stable docking models of biopolymer-ligand, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for searching stable docking models of biopolymer-ligand will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-152946

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.